Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy

计划入组 716 人 · 首次发布于 2022 年 10 月 17 日

Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before Hepatectomy

计划入组 96 人 · 首次发布于 2022 年 7 月 5 日

Effects of One-handed and Two-handed Mask Ventilation Techniques on Global and Regional Lung Ventilation

计划入组 80 人 · 首次发布于 2020 年 11 月 5 日

68Ga-GSI

Fecal Microbiota Transplantation（German Cancer Research Center）

Neoantigen-Targeted ppDC Vaccine(Uclas Jonsson Comprehensive Cancer Center)

Fudan University Shanghai Cancer Center

China

CENTER WEST CANCER

United States

Providence Cancer Center

Ensem Therapeutics Expands ETX-636 Trial to China, Targeting PI3Kα Mutations in Cancer

Chinese-Developed HER2-Targeting ADC TQB2102 Achieves 77% Complete Response Rate in Phase II Breast Cancer Trial

Phase 2b Trial of Glecirasib in KRAS G12C-Mutated Non-Small-Cell Lung Cancer